Hypersensitivity to the dequalinium chloride or to any of the excipients of Gynoflor.
Malignant changes (estrogen-dependent tumours) in the breast, uterus or vagina; endometriosis (suspected or manifest); severely inflamed, suppurated, infiltrated vaginitis; vaginal haemorrhage of unknown origin; females who are not yet sexually mature.